HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The host response in graft versus host disease. I. Radiosensitive T cells of host origin inhibit parental anti-F1 cytotoxicity in murine chronic graft versus host disease.

Abstract
Murine graft versus host (GVH) disease takes two forms depending on the parental/F1 strain combination employed. Acute lethal GVH disease is characterized by anemia, lymphopenia, hypogammaglobulinemia, profound anti-F1 cytotoxicity, and the loss of cytotoxic potential against third-party alloantigen. In contrast to this, chronic GVH disease is characterized by polyclonal B cell activation, auto-antibody production, no anti-F1 cytotoxicity, and retained cytotoxicity against allotargets. We now report that this marked disparity in disease expression results from a radio-sensitive host mechanism which protects the F1 mouse from parental anti-F1 cytotoxicity in mice undergoing chronic GVH disease. Cellular analysis revealed that protection in chronic GVH disease is mediated by a phenotypically complex system of genetically unrestricted radiosensitive T cells of F1 origin. These cells fail to functionally emerge in mice undergoing acute lethal GVH disease.
AuthorsA B Singh, K Hiehle, M Singh, A E Jetzt, S M O'Connell, R A Mann
JournalCellular immunology (Cell Immunol) Vol. 151 Issue 1 Pg. 24-38 (Oct 01 1993) ISSN: 0008-8749 [Print] Netherlands
PMID8402929 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • H-2 Antigens
Topics
  • Acute Disease
  • Animals
  • Chronic Disease
  • Crosses, Genetic
  • Cytotoxicity, Immunologic (physiology)
  • Graft vs Host Disease (genetics, immunology)
  • H-2 Antigens (immunology)
  • Male
  • Mice
  • Mice, Inbred Strains
  • Radiation Tolerance
  • Self Tolerance
  • T-Lymphocytes (immunology, radiation effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: